Cargando…
Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine
The BBIBP-CorV severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inactivated vaccine has been authorized for emergency use and widely distributed. We used single-cell transcriptome sequencing to characterize the dynamics of immune responses to the BBIBP-CorV inactivated vaccine. In additi...
Autores principales: | Yin, Jianhua, Zhao, Yingze, Huang, Fubaoqian, Yang, Yunkai, Huang, Yaling, Zhuang, Zhenkun, Wang, Yanxia, Wang, Zhifeng, Lin, Xiumei, Zheng, Yuhui, Zhou, Wenwen, Wang, Shuo, Xu, Ziqian, Ye, Beiwei, Guo, Yaxin, Lei, Wenwen, Li, Lei, Tian, Jinmin, Gan, Jinxian, Wang, Hui, Wang, Wei, Ma, Peiyao, Liu, Chang, Wei, Xiaoyu, Shi, Xuyang, Wang, Zifei, Wang, Yang, Liu, Ying, Yang, Mingming, Yuan, Yue, Song, Yumo, Ma, Wen, Huang, Zhuoli, Liu, Ya, Huang, Yunting, Lu, Haorong, Liu, Peipei, Liang, Hao, Hou, Yong, Xu, Xun, Liu, Longqi, Zhang, Yuntao, Wu, Guizhen, Gao, George F., Jin, Xin, Liu, Chuanyu, Yang, Xiaoming, Liu, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719934/ https://www.ncbi.nlm.nih.gov/pubmed/36506806 http://dx.doi.org/10.1016/j.xinn.2022.100359 |
Ejemplares similares
-
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
por: Xia, Shengli, et al.
Publicado: (2021) -
Correlation of gut microbiota and metabolic functions with the antibody response to the BBIBP-CorV vaccine
por: Tang, Bo, et al.
Publicado: (2022) -
Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial
por: Kaabi, Nawal Al, et al.
Publicado: (2022) -
Safety and immunogenicity of a hybrid-type vaccine booster in BBIBP-CorV recipients in a randomized phase 2 trial
por: Kaabi, Nawal Al, et al.
Publicado: (2022) -
Real-world study of the effectiveness of BBIBP-CorV (Sinopharm) COVID-19 vaccine in the Kingdom of Morocco
por: Zhang, Yaowen, et al.
Publicado: (2022)